glp 1 inhibitor drugs List of approved and pending GLP-1 medications Dosage of GLP-1 analogues |

After their success in the obesity field, GLP-1 agonists are gaining interest in addiction treatment

It has a natural yellow pigment (dye) which also shows as bright yellow fluorescence under UV light.

Genes affect how well semaglutide (Ozympic) and tirzepatide work

Gastrointestinal (GI) adverse eventsparticularly nausea, vomiting, diarrhea, and constipationare the most common side effects, generally emerging during dose escalation and resolving over time

To further note, in the field of weight-loss treatment, significant work is underway in parallel, on GIP agonist, amylin agonist, glucagon agonist, PYY agonist, either separately or in combination especially with GLP-1 agonist.

Here, the authors review the physiological roles of GLP-1, the potential renoprotective mechanisms of incretin-based therapies and the available renal outcome data from clinical trials.